David Tsao

You might notice we look a little different today as we've rolled out a fresh new look. But our values and mission remain the same. Check out our website: billiontoone.com Curious about our name? Watch this 1 min video: ow.ly/NSKj50JPVJx vimeo.com/723119678/f5ce…

We are thrilled to announce the closure of our #SeriesC funding round with premier global investors. $125M to help us continue to grow our team and move #nipt and #liquidbiopsy forward. ow.ly/YHgh50Iw1wa

Congrats, Nancy!

BillionToOne Closes $55M Series B Funding, Builds Out a 36,000 Sqft Space to Meet Growing Demand newswire.com/news/billionto…

Our preprint describing this work is now available on biorxiv: biorxiv.org/content/10.110…

Thanks to the BillionToOne team for all the hard work pulling this together! Next step is to start manufacturing test kits and obtain Emergency Use Authorization from the FDA. If you're a Lab Director or contract kit manufacturer, we're looking for partners.

We’ve been working hard @BillionToOne on a new COVID-19 test that scales testing to everyone in the US billiontoone.com/covid-19. It (1) re-purposes existing infrastructure, (2) eliminates time-consuming RNA extraction, and (3) enables a distributed system for COVID-19 testing.

@NathanGrubaugh We’re working on using Sanger sequencing to do thousands of tests per day, per instrument. billiontoone.com/covid-19

@zaid CLIA rules that dictate that all analytic processing must happen end-to-end within a single CLIA-certified lab.

@dtsao Which regulations specifically?